Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Positive phase III clinical trial results received for Olux

Nov. 12, 1998

Team from Angiotech demonstrates paclitaxel's potential as an antipsoriatic

Nov. 12, 1998

Idec Pharmaceuticals: Q3 1998 highlights

Nov. 4, 1998

AlloDerm used to successfully treat rare congenital condition in newborn

Nov. 3, 1998

Aminoacyl sulfamides synthesized at Cubist claimed for psoriasis

Nov. 2, 1998

ICN obtains rights to Senetek skincare cosmeceutical

Oct. 29, 1998

RU-58841 shows potential as topical agent for alopecia and other skin disorders

Oct. 28, 1998

Idec commences clinical trials with PRIMATIZED anti-B7 antibody in psoriasis

Oct. 27, 1998

Tacalcitol lotion equivalent to ointment in animal study

Oct. 23, 1998

Fexofenadine in the treatment of chronic idiopathic urticaria

Oct. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...